Study guide
4.2 Non-Beta-Lactam Antibacterials
DHA Pharmacist Licensing Assessment PHO5481
Track your progress as you read
Finished sections get a check mark.
1 Exam Overview & Licensing Pathway
1.1 Current Exam Facts & Format 1.2 Eligibility, PQR & the Sheryan Application Process 1.3 Study Strategy & Test-Day Plan
2 Cardiovascular Pharmacology
2.1 Antihypertensives & RAAS Agents 2.2 Heart Failure & Antiarrhythmic Drugs 2.3 Lipid-Lowering & Antianginal Agents
3 Endocrine & Metabolic Pharmacology
3.1 Insulin & Oral Antidiabetic Agents 3.2 Thyroid, Bone & Calcium Agents 3.3 Corticosteroids & Other Hormonal Agents
4 Anti-Infective Pharmacology
4.1 Beta-Lactam Antibiotics 4.2 Non-Beta-Lactam Antibacterials 4.3 Antifungals, Antivirals & Antituberculars
5 CNS, Psychiatric & Pain Pharmacology
5.1 Psychiatric Pharmacology 5.2 Antiepileptics & Neurologic Agents 5.3 Analgesics: NSAIDs, Opioids & Migraine
6 Respiratory, GI & Hematology Pharmacology
6.1 Respiratory Pharmacology 6.2 Gastrointestinal Pharmacology 6.3 Anticoagulants, Antiplatelets & Hematology Agents
7 Pharmaceutical Care: Cardiometabolic Disease
7.1 Diabetes Management & Counseling 7.2 Hypertension & Dyslipidemia Management 7.3 Heart Failure & Anticoagulation Management
8 Pharmaceutical Care: Respiratory, Rheumatology & Infection
8.1 Asthma & COPD Management 8.2 Gout, Pain & Rheumatologic Care 8.3 Infection Management & Antimicrobial Stewardship
9 Counseling, Monitoring & Special Populations
9.1 Patient Counseling, Adherence & Health Literacy 9.2 Therapeutic Monitoring & Laboratory Interpretation 9.3 Pregnancy, Pediatrics, Geriatrics & Organ Impairment 9.4 Pharmacoeconomics & Formulary Decision Making
10 Pharmaceutical Calculations I
10.1 Concentration, Ratio & Percentage Strength 10.2 Weight-Based & BSA Dosing 10.3 Dilution, Concentration & Alligation
11 Pharmaceutical Calculations II
11.1 Infusion Rates & IV Flow Calculations 11.2 Dispensing Quantities & Days' Supply 11.3 Compounding Calculations, Isotonicity & Milliequivalents
12 UAE Pharmacy Law & Regulation
12.1 UAE Regulatory Framework & Licensing Authorities 12.2 Medicine Registration, Pricing & Supply Chain 12.3 Prescription Requirements & Validity
13 Controlled Drugs, Ethics & Pharmacovigilance
13.1 Controlled & Semi-Controlled Medicines in the UAE 13.2 Ethics, Confidentiality & Generic Substitution 13.3 Pharmacovigilance, Recall & Medicine Disposal
14 Pharmacokinetics I: ADME
14.1 Absorption & Bioavailability 14.2 Distribution & Protein Binding 14.3 Metabolism & Elimination
15 Pharmacokinetics II: Kinetics, Dosing & TDM
15.1 Half-Life, Clearance & Kinetic Order 15.2 Loading & Maintenance Dosing 15.3 Therapeutic Drug Monitoring
16 OTC Medicines & Self-Care
16.1 Cough, Cold & Allergic Rhinitis 16.2 GI Self-Care: Heartburn, Constipation & Diarrhoea 16.3 Pain & Fever Self-Care 16.4 Referral Red Flags, Emergency Contraception & Skin
17 Medication Safety
17.1 High-Alert Medications & Error-Prone Abbreviations 17.2 Medication Reconciliation & Duplicate Therapy 17.3 Adverse Drug Reactions & Hypersensitivity Recognition
18 Sterile & Nonsterile Compounding
18.1 Aseptic Technique & Compounding Environments 18.2 Parenteral, TPN & Cytotoxic Preparation 18.3 Nonsterile Compounding
19 Pharmaceutics, Biopharmaceutics & Toxicology
19.1 Dosage Form Design & the Biopharmaceutics Classification System 19.2 Dissolution & Excipients 19.3 Toxicology: Poisoning Recognition & Antidotes
20 Infection Control, Natural Products, Medicinal Chemistry & Pharmacogenomics
20.1 Infection Control & Immunization 20.2 Pharmacognosy & Dietary Supplements 20.3 Medicinal Chemistry Essentials 20.4 Clinical Pharmacogenomics
4.2 Non-Beta-Lactam Antibacterials
Key Takeaways Explain This Topic AI
Clarithromycin is a strong CYP3A4 inhibitor (dangerous with statins) and macrolides prolong the QT interval; azithromycin has a long half-life enabling 3–5 day courses
Fluoroquinolones cause tendinopathy and Achilles rupture (risk rises over age 60 and with corticosteroids), are avoided in pregnancy and children, and are chelated by calcium, iron, magnesium, and antacids
Gentamicin kills in a concentration-dependent fashion and is dosed once daily with level monitoring; nephrotoxicity and irreversible ototoxicity are its dose-limiting toxicities
Vancomycin covers MRSA, is monitored by AUC/MIC 400–600 (trough 15–20 mg/L for serious infections), and red-man reaction is an infusion-rate-related histamine reaction, not an allergy
Trimethoprim-sulfamethoxazole inhibits CYP2C9 (spiking warfarin INR), causes hyperkalemia, and antagonizes folate; linezolid plus an SSRI risks serotonin syndrome; clindamycin carries the highest Clostridioides difficile risk
Last updated: August 2026
Macrolides
Macrolides — azithromycin , clarithromycin , erythromycin — bind the 50S ribosomal subunit , blocking translocation and protein synthesis; they are generally bacteriostatic . Their clinical value is coverage of atypical pathogens (Legionella, Mycoplasma pneumoniae, Chlamydophila) plus respiratory streptococci, making azithromycin a partner to ceftriaxone in community-acquired pneumonia. Azithromycin's very long half-life allows once-daily 3–5 day courses; clarithromycin is a component of Helicobacter pylori eradication regimens.
Exam-critical cautions: clarithromycin and erythromycin are potent CYP3A4 inhibitors — co-prescription with simvastatin can precipitate rhabdomyolysis, and levels of many substrates (some calcium-channel blockers, DOACs) rise. All macrolides prolong the QT interval and should be used cautiously with other QT-prolonging drugs or in congenital long-QT. Erythromycin also causes dose-related gastrointestinal motility stimulation (nausea, cramping).
Fluoroquinolones
Fluoroquinolones — ciprofloxacin , levofloxacin , moxifloxacin — inhibit bacterial DNA gyrase (topoisomerase II) and topoisomerase IV , and are bactericidal with concentration-dependent killing. Ciprofloxacin is the most active against Pseudomonas and is used for complicated UTIs and gastroenteritis; levofloxacin and moxifloxacin are "respiratory" fluoroquinolones with reliable Streptococcus pneumoniae cover. Moxifloxacin adds anaerobic activity but is not used for UTIs because urinary excretion is poor, and it carries the greatest QT prolongation of the class.
Safety profile the DHA exam loves: tendinopathy and Achilles tendon rupture (risk increases over age 60, with corticosteroid use, and after organ transplantation); avoidance in pregnancy and children because of cartilage toxicity in juvenile animal studies; QT prolongation ; dysglycemia; CNS effects including confusion and rare seizures; photosensitivity; and an association with aortic aneurysm/dissection in at-risk patients. Chelation is a classic dispensing question: divalent and trivalent cations — calcium, iron, magnesium, zinc, antacids, sucralfate, dairy — bind fluoroquinolones and block absorption, so administration should be separated (typically take the antibiotic 2 hours before or 4–6 hours after the cation).
Tetracyclines
Doxycycline (and the older tetracyclines) binds the 30S ribosomal subunit , is bacteriostatic, and covers atypicals, rickettsiae, chlamydia, Borrelia (Lyme disease), acne, and malaria prophylaxis. Key counseling points: photosensitivity (advise sun protection), pill esophagitis (take with a full glass of water and remain upright for at least 30 minutes), and chelation by the same cations as fluoroquinolones. Tetracyclines are contraindicated in pregnancy and in children under 8 years because they chelate calcium in developing teeth and bone, causing permanent discoloration. Doxycycline is the exception that does not need renal dose adjustment.
Aminoglycosides
Gentamicin (with tobramycin and amikacin) binds the 30S subunit , causes misreading of mRNA, and is bactericidal with concentration-dependent killing and a post-antibiotic effect — the pharmacodynamic rationale for extended-interval (once-daily) dosing , which maximizes the peak-to-MIC ratio while reducing toxicity. Spectrum is aerobic gram-negative bacilli; gentamicin is also used at low, synergistic doses with a beta-lactam for gram-positive endocarditis. Aminoglycosides are not absorbed orally and are eliminated renally, so therapeutic drug monitoring is mandatory: peak and trough levels (or a random level on the nomogram) with once-daily dosing. Toxicity is the exam focus: nephrotoxicity (usually reversible acute tubular necrosis) and ototoxicity (vestibular and cochlear, potentially irreversible ), worsened by loop diuretics, vancomycin, and prolonged courses.
Vancomycin
Vancomycin is a glycopeptide that binds the D-Ala-D-Ala terminus of peptidoglycan precursors, blocking cell-wall synthesis. It covers gram-positives only, including MRSA , and is given intravenously for serious infections; oral vancomycin is not absorbed and is used purely for Clostridioides difficile colitis . Monitoring has moved to AUC/MIC-guided dosing with a target ratio of 400–600 (assuming a MIC of 1 mg/L); where trough-based monitoring is still used, troughs of 15–20 mg/L are targeted for serious MRSA infections such as bacteremia, endocarditis, and pneumonia. Toxicities: nephrotoxicity (additive with aminoglycosides and piperacillin-tazobactam), ototoxicity at high levels, and the red-man (vancomycin infusion) reaction — flushing and pruritus of the face, neck, and torso from histamine release when infused too quickly. It is not an allergy : slow the infusion over at least 60–120 minutes and premedicate with an antihistamine if needed.
Folate Antagonists, Nitrofurantoin, and the Anaerobe Agents
Trimethoprim-sulfamethoxazole (co-trimoxazole) sequentially blocks folate synthesis — sulfamethoxazole inhibits dihydropteroate synthase and trimethoprim inhibits dihydrofolate reductase — giving bactericidal synergy against urinary pathogens, Pneumocystis jirovecii pneumonia (treatment and prophylaxis), and MRSA skin infections. High-yield problems: trimethoprim inhibits CYP2C9 , raising S-warfarin levels and spiking the INR ; it blocks renal sodium channels (ENaC) like a potassium-sparing diuretic, causing hyperkalemia — dangerous with ACE inhibitors, ARBs, and spironolactone — and raises serum creatinine by inhibiting tubular secretion without truly reducing GFR. Additional risks: sulfa allergy including Stevens-Johnson syndrome , bone-marrow suppression, and folate antagonism — avoid in the first trimester of pregnancy (neural tube defect risk) and near term (kernicterus risk).
Nitrofurantoin is concentrated in urine and used only for uncomplicated lower UTI (cystitis) — never pyelonephritis or systemic infection because therapeutic serum and tissue levels are not achieved. Efficacy falls as renal function declines; current guidance restricts use to creatinine clearance of at least 30 mL/min . Watch for pulmonary toxicity (acute pneumonitis; chronic fibrosis with long-term prophylaxis), peripheral neuropathy, hemolysis in G6PD deficiency , and harmless brown urine discoloration. Proteus and Pseudomonas are intrinsically resistant.
Metronidazole is activated under anaerobic conditions to free radicals that damage DNA; it covers anaerobes (intra-abdominal and pelvic infection, bacterial vaginosis) and protozoa (Giardia, Trichomonas, Entamoeba). Its defining interaction is the disulfiram-like reaction with alcohol — flushing, vomiting, and tachycardia — so patients must avoid alcohol during therapy and for at least 48–72 hours after. It also inhibits CYP2C9 and can raise warfarin effect; metallic taste is common.
Clindamycin (50S inhibitor) covers gram-positives and anaerobes and is used in severe skin infections, aspiration pneumonia, and toxin-mediated streptococcal disease; its label warning is the highest association with C. difficile diarrhea of any commonly used antibiotic. Linezolid , an oxazolidinone for MRSA and vancomycin-resistant enterococci, is a reversible monoamine oxidase inhibitor — combining it with SSRIs or other serotonergic drugs risks serotonin syndrome , and courses beyond two weeks cause reversible thrombocytopenia and myelosuppression. Fosfomycin inhibits MurA (an early cell-wall enzyme) and is given as a single 3 g sachet for uncomplicated cystitis , retaining activity against many ESBL-producing E. coli.
High-Yield Summary: Non-Beta-Lactam Antibacterials
The table consolidates the mechanism and the single most-tested toxicity or interaction for each class — the pairings the DHA exam repeatedly rewards. Use it as a last-week revision grid: cover the right-hand column and recall the toxicity before checking it.
Class / agent Mechanism Signature toxicity or high-yield interaction
Macrolides (azithromycin, clarithromycin, erythromycin) Bind 50S subunit; block translocation (bacteriostatic) Clarithromycin/erythromycin inhibit CYP3A4 (rhabdomyolysis with statins); all prolong QT ; azithromycin's long half-life enables 3–5 day courses
Fluoroquinolones (cipro, levo, moxi) Inhibit DNA gyrase + topoisomerase IV (bactericidal) Tendinopathy / Achilles rupture (age >60, corticosteroids); cation chelation (Ca, Fe, Mg, antacids — separate dosing); avoid in pregnancy and children; moxifloxacin greatest QT effect
Tetracyclines (doxycycline) Bind 30S subunit (bacteriostatic) Photosensitivity , pill esophagitis (take upright with water); teeth discoloration under 8 yr and in pregnancy; cation chelation
Aminoglycosides (gentamicin) Bind 30S; misread mRNA (bactericidal, concentration-dependent) Once-daily dosing from peak/MIC + post-antibiotic effect; nephrotoxicity and irreversible ototoxicity ; mandatory therapeutic drug monitoring
Vancomycin Glycopeptide binds D-Ala-D-Ala; blocks cell-wall synthesis MRSA cover; AUC/MIC 400–600 (trough 15–20 mg/L); red-man reaction is infusion-rate histamine release, not allergy; oral form used for C. difficile colitis
TMP-SMX (co-trimoxazole) Sequential folate antagonism (dihydropteroate synthase + DHFR) CYP2C9 inhibition raises warfarin INR; hyperkalemia (ENaC blockade); folate antagonism — avoid in pregnancy; Stevens-Johnson syndrome
Nitrofurantoin Concentrated in urine only Cystitis only (not pyelonephritis); restrict to CrCl ≥30 mL/min; pulmonary toxicity , G6PD hemolysis
Metronidazole Anaerobic free radicals damage DNA Disulfiram-like reaction with alcohol (avoid during and 48–72 h after); CYP2C9 inhibition raises warfarin effect
Clindamycin 50S inhibitor Highest Clostridioides difficile risk of any commonly used antibiotic
Linezolid Oxazolidinone (protein synthesis) Reversible MAO inhibitor → serotonin syndrome with SSRIs; courses >2 weeks cause reversible thrombocytopenia
Fosfomycin Inhibits MurA (early cell-wall step) Single 3 g sachet for uncomplicated cystitis; retains activity against many ESBL-producing E. coli